Jeffrey Eisele - Jan 22, 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Development Officer
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
Stock symbol
APLS
Transactions as of
Jan 22, 2025
Transactions value $
-$39,279
Form type
4
Date filed
1/23/2025, 03:26 PM
Previous filing
Jan 14, 2025
Next filing
Jan 30, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$39.3K -1.29K -2.27% $30.43 55.6K Jan 22, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 21, 2025.